# PTG-100 for Patients With Celiac Disease

> **NCT04524221** · PHASE1 · COMPLETED · sponsor: **Nielsen Fernandez-Becker** · enrollment: 12 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** PTG-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04524221
- **Lead sponsor:** Nielsen Fernandez-Becker
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2022-04-03
- **Final completion:** 2022-04-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524221, "PTG-100 for Patients With Celiac Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04524221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*